treatment, MDT allows a reduction of the overall dosage of chemotherapeutic drugs, resulting in reduced side effects for the patients. It is worth mentioning that at the same time an increased dosage of chemotherapeutic agent in the tumor area can be achieved [1] . For this purpose, chemotherapeutic drugs are bound to magnetic nanoparticles and are applied intra arterially in the vicinity of the tumor. These particles and thereby the medical agent can be accumulated in the tumor area by means of an external static magnetic field. In the currently most extensive preclinical animal study for MDT a high efficiency could be shown [2] .
The successful MDT treatment requires a well-defined concentration of medical agent in the tumorous area and thereby requires monitoring of the nanoparticles. There are several modes to detect magnetic nanoparticles that are already in clinical use, such as Magnetic Resonance Imaging (MRI). MRI is a well-known technique and is used as standard imaging technique in clinics. There are other imaging techniques under development that are able to visualize the nanoparticle-loaded tissue, such as Magnetic Particle Imaging. For this new imaging technique, superparamagnetic nanoparticles are used as contrast agents [3] . Both techniques have in common that they need relatively large technical equipment and are very cost intensive.
In contrast, ultrasound is a widespread and less expensive imaging technology. However, the size of nanoparticles is challenging ultrasound-based detection, as they are not visible directly due to their weak backscattering. Therefore, standard ultrasound imaging techniques like Bmode image technique are not capable of detecting nanoparticles. Nevertheless, it has been demonstrated that ultrasound imaging techniques can be exploited to detect magnetic nanoparticles [4] . This sonographic detection of magnetic nanoparticles is known as Magnetomotive Ultrasound (MMUS). MMUS is based on nanoparticle movement excitations by means of an external time variable magnetic field. However, so far no MMUS algorithm has been capable to detect the nanoparticle concentration quantitatively. Therefore, we present an ultrasound-based approach that is capable to measure quantitatively the concentration of iron oxide nanoparticles in biological tissue.
Abstract:
Research in biomedical nanotechnology led already to a variety of applications of nanoparticles in diagnosis as well as in therapy. One of these medical applications is Magnetic Drug Targeting, a promising cancer treatment technique. The aim of this medical attendance is a local chemotherapeutic treatment of the cancerous tissue. For this purpose, chemotherapeutic drugs are bound to magnetic nanoparticles and accumulated in the tumor area by means of an external static magnetic field. Hereby, a well-defined particle concentration in the cancerous tissue requires monitoring of the particle accumulation. Therefore, we present an ultrasound imaging technique that is capable of detecting quantitatively the concentration of iron oxide nanoparticles in biological tissue. The evaluation is based on the variation of the speed of sound of an induced shear wave with respect to the particle concentration. 
Introduction
Magnetic nanoparticles offer several possibilities in medical diagnosis as well as in therapy. One of these medical applications is Magnetic Drug Targeting (MDT), a cancer treatment technique, which enables a local chemotherapeutic treatment. In comparison to traditional chemotherapeutic The measurement is based on the differences between the bulk acoustic material properties of the utilized nanoparticles and of the biological tissue. The speed of sound values as well as the acoustic impedances of the particle-loaded tissue differ from those of the tissue which is free from particles. For example, the velocity of low frequency shear waves in tissue is higher in tissue enriched by iron oxide particles than in particle free tissue. Similar to shear wave elastography, a shear wave can be induced into the target tissue and the shear wave speed of sound can be tracked. The variation of the spatial distribution of the speed of sound with respect to time permits conclusions regarding the local and temporal enrichment of nanoparticles.
Measurements
Two different measurements have been performed. As biological tissue mainly consists out of water, in a first step, the impact of iron oxide nanoparticles on the speed of sound of pure water has been investigated. In a second step, a commercial shear wave elastography mode has been exploited to detect the particle-loaded area in a tissue mimicking phantom. Figure 1 shows the measurement setup to investigate the influence of the presence of iron oxide nanoparticles dissolved in pure water on the speed of longitudinal wave ultrasound c L in water. It consists of an ultrasonic transducer (Olympus V306) and a mold that contains the fluid. The transducer is controlled via a pulser-receiver (Olympus Model 5900 PR) and emits as well as receives ultrasonic pulses. The speed of sound can thereupon be evaluated via the time of flight of the ultrasonic pulses that are reflected on the bottom of the mold.
In order to eliminate the temperature dependency of the speed of sound, the measurements are performed in a climatic chamber (CTS CV-70/200) at a constant temperature of 10°C. This rather low temperature is chosen as the utilized nanoparticle suspension is only guaranteed to behave chemically stable over a long period of time at temperatures lower equal to 10°C. Figure 2 shows the measurement setup to test the ability of shear waves to detect nanoparticle-loaded areas by means of evaluation of the shear wave speed of sound. Therefore, a tissue-mimicking phantom was made out of polyvinyl alcohol (PVA). PVA is suitable to be used as tissuemimicking material in medical ultrasound applications [5] and allows low frequency shear wave propagation like in biological tissue. The tissue-mimicking phantom contains a nanoparticle-loaded area in which the nanoparticles are randomly distributed. A shear wave is induced employing the commercial push pulse elastography mode of a Siemens Acouson S2000 ultrasound unit. The linear array 9L4 (4-9 MHz) was used as ultrasonic probe.
Methodology and Results
According to Figure 1 , the speed of sound c L was evaluated via the time of flight of an ultrasonic pulse t and the distance d of the transducer to the bottom of the mold (c L = 2d / t). The measurement showed that in comparison to pure water a particle concentration of approximately 2.5 x 1e14 particles per ml the speed of sound increases from 1445 m/s to 1464 m/s. Hereby, the particles have a diameter of 10 nm. The concentration of 2.5 x 1e14 particles per ml corresponds to the concentration that is targeted to apply to the patients in a prospective application. It is worth mentioning that this configuration only allows to determine the speed of sound of the longitudinal wave c L . However, if c L increases in water, we can assume that the corresponding c L in the phantom material as well as in biological tissue increase in a similar way with the increasing particle density. And it can also be expected that the shear wave velocity in the tissue-mimicking medium c S also increases with increasing particle concentration as the shear wave velocity is always proportional to the longitudinal wave velocity c L in media, which allow shear wave propagation [6] . Figure 3 shows the measurement according to the setup of Figure 2 . The result shows that the nanoparticle-loaded tissue possesses an increased shear wave speed of sound. Whereas in tissue that is free from particles the shear wave speed of sound is approximately 3 m/s on average, the particle-loaded tissue has a shear wave speed of sound up to 5.5 m/s. In order to assess the quantitative particle concentration, of course the distribution of the shear wave velocity in the particle free state has to be known. As the presented imaging technique is contemplated as a monitoring system during a chemotherapeutical treatment, this initial state is assumed to be known.
Outlook
The measurements have shown that shear waves are indeed capable to detect iron oxide nanoparticles in biological tissue and in biological tissue mimicking material, respectively. Further investigations will focus on the quantitative determination of the particle concentration, which requires accurate knowledge of the structure and the properties of the utilized nanoparticles. In case of successful investigations also measurements on real biological tissue perfused by magnetic nanoparticles can be considered. 
